Home

ABOUT

Editorial

PRESS RELEASES

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

SUBSCRIBE

Market Reports

FDA

Executives

Funding

Non Profits

Hospitals

Acquisitions

Health

Biotechnology News Magazine

HomeCyberknifeAccuray Unveils VOLO™ Ultra, the Latest Innovation for the Radixact® System, at...

Accuray Unveils VOLO™ Ultra, the Latest Innovation for the Radixact® System, at ASTRO 2021

Showcases Multiple Forward-Looking Radiotherapy Solutions Designed to Enhance the Treatment Experience for Medical Care Teams and Their Patients

MARKET REPORTS

Global Cerebrospinal Fluid Drainage Catheter Market (2021 to 2027) – by Application, Type and Regional Outlook

The Global Cerebrospinal Fluid Drainage Catheter Market size is expected to reach $402.6 Million by 2027, rising at a market growth of 8.6% CAGR during the forecast period. For the treatment of hydrocephalus, placement of cerebral spinal fluid (CSF) shunt systems is becoming a common medical and life-saving procedure for the majority of the patients.

United States Insulin Delivery Devices Market Report 2021

This new report provides an in-depth assessment of the U.S insulin delivery devices market dynamics, opportunities, future road-map, competitive landscape and discusses major trends.

Global $45 Billion Endoscopy Market Insights & Forecasts to 2025

The global endoscopy market is predicted to reach US$45.28 billion in 2025, growing, at a CAGR of 7.50%, for the duration spanning 2021-2025.

Global Remote Monitoring Devices Market Research Report (2021 to 2026)

Global Remote Monitoring Devices Market size was estimated at USD 1,035.35 million in 2020, is expected to reach USD 1,170.22 million in 2021.

Accuray Incorporated (NASDAQ: ARAY) announced today the company is showcasing its new VOLO™ Ultra for the Radixact® System, at ASTRO 2021. VOLO Ultra, a new way of planning with the Accuray Precision® Treatment Planning System, enables users to plan with ease, optimize with quality, and deliver treatments with efficiency.

The American Society for Radiation Oncology’s (ASTRO) 63rd annual meeting will take place October 24-27, 2021, in Chicago. Accuray will be in attendance at booth #403, sharing information on how its novel CyberKnife® and Radixact platforms and advanced software solutions can help expand the curative potential of radiation therapy.

“Accuray is thrilled to attend ASTRO 2021 and have the opportunity to engage with our valued customers. We are focused on positioning them for success in an ever evolving healthcare environment,” said Suzanne Winter, president of Accuray. “Our artificial intelligence (AI)-driven Synchrony® 4D dynamic delivery technology on the CyberKnife and Radixact Systems, ClearRT™ imaging, and VOLO Ultra are making it easier than ever to provide precise and accurate radiation treatments – but we aren’t stopping here. We continue to pursue the development of game-changing innovations that have the potential to bring a paradigm shift in radiation delivery and patient outcomes.”

Accuray ASTRO 2021 Highlights: Unique Advances in Software and Imaging Solutions

  • VOLO Ultra*: VOLO Ultra is the latest evolution of our planning solution, the Accuray Precision Treatment Planning System. It helps accelerate Radixact and TomoTherapy® treatments so clinicians can treat more patients each day. It includes a state-of-the-art optimizer with a modern and fast gradient-based algorithm, designed to provide optimal plan quality for every treatment.
  • ClearRT helical fan-beam kVCT imaging**: ClearRT is a one-of-a-kind imaging solution integrated with the Radixact System – a true workhorse system – to produce exceptional diagnostic-like quality CT images, quickly and cost-effectively. ClearRT offers the widest and longest field of view enabling clinicians to see more, know more and do more, and providing a new level of precision and accuracy in the treatment of almost any indication that would benefit from radiotherapy, from the simplest to the most complex.
  • RayStation*** for the CyberKnife**** robotic radiosurgery platform: RayStation treatment planning support for the robotic CyberKnife M6™ and S7™ Systems will help enable clinicians to create treatment plans for these advanced systems and other conventional radiotherapy devices using the same software solution. RayStation will make it easier to seamlessly integrate the CyberKnife System within a radiation oncology department, increasing access to the only device capable of delivering sub-millimetric stereotactic treatments anywhere in the body with speed, efficiency and accuracy – all without the need for human intervention.

Symposium: Go ITV-free and Gating-free with Accuray

  • October 26th, 2021, at 12:15 pm CT in Theater 1, Innovation Hub
  • Hear how Synchrony® enables ITV-free and gating-free approaches to stereotactic body radiation therapy (SBRT) treatments. Three practitioners will share their real-world clinical experiences using Synchrony® with the Radixact® and CyberKnife® Systems.

Click here for more information or to register for the symposia.

Accuray Exchange in Radiation Oncology (AERO) Sessions: Daily Throughout the Meeting
The 15-minute talks on best practices will be offered in the AERO bar within the Accuray booth. All presentations will be available on AccurayExchange.com. Topics include:

  • Rationale and overview of CyberKnife prostate SBRT
  • Efficiency gains with CyberKnife VOLO™ optimizer: A user’s perspective
  • VOLO™ Ultra, a new way of planning with Accuray Precision® Treatment Planning System, architected to accelerate
  • Implementing ClearRT™ for the Radixact System
  • CyberKnife Synchrony approach for pancreas treatments
  • The impact of the Radixact with Synchrony on patient treatments
  • Introducing CyberKnife planning on RayStation®
  • Brainlab Elements: improved target definition through automation

*VOLO™ Ultra Option for Accuray Precision® Treatment Planning System is 510(k) cleared. It is not CE marked and availability is subject to regulatory clearance or approval in some markets.
**ClearRT™ Helical kVCT Imaging for the Radixact® Treatment Delivery System is not available for sale in all markets. ClearRT may be subject to international regulatory approval or licensing processes such that the availability of these products may vary according to geographical location.
***RayStation: Subject to regulatory clearance in some markets.
****Accuray CyberKnife® System: 510(k) cleared. Subject to regulatory clearance in some markets.

spot_img

DON'T MISS

Cancer Patients Overlooked in COVID-19 Vaccine Rollout

For the new study, researchers sought to determine the proportion of states that elected to follow CDC recommendations. They identified every states’ COVID vaccination webpage through keyword-based internet search and set out to identify information about vaccination for cancer patients.

MRI Reveals Altered Brain Structure in Fetuses Exposed to Alcohol

For the study, researchers recruited 500 pregnant women who were referred for a fetal MRI for clinical reasons. On an anonymous questionnaire, 51of the women admitted to consuming alcohol during their pregnancy.

Popular Blood Thinners May Lead to Brain Bleeding after Head Injury

A three-year study of more than 1,000 patients found that the risk of delayed intracranial hemorrhage and death following head trauma was significantly higher for adults taking older blood-thinning medications.

Enrollment Completed for Multi-Center Study for Diabetic Foot Ulcers

The data collected from the study will bolster the existing clinical database of DFU images and clinical data to train and increase the current 83.3% decision support accuracy of the DeepView® algorithm for DFU.

Our Sister Publication: Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy